Immune Correlates Analysis of the mRNA-1273 COVID-19 Vaccine Efficacy Trial

Peter B. Gilbert, David C. Montefiori, Adrian McDermott, Youyi Fong, David Benkeser, Weiping Deng, Honghong Zhou, Christopher R. Houchens, Karen Martins, Lakshmi Jayashankar, Flora Castellino, Britta Flach, Bob C. Lin, Sarah O’Connell, Charlene McDanal, Amanda Eaton, Marcella Sarzotti-Kelsoe, Yiwen Lu, Chenchen Yu, Bhavesh Borate, Lars W. P. van der Laan, Nima Hejazi, Chuong Huynh, Jacqueline Miller, Hana M. El Sahly, Lindsey R. Baden, Mira Baron, Luis De La Cruz, Cynthia Gay, Spyros Kalams, Colleen F. Kelley, Mark Kutner, Michele P. Andrasik, James G. Kublin, Lawrence Corey, Kathleen M. Neuzil, Lindsay N. Carpp, Rolando Pajon, Dean Follmann, Ruben O. Donis, Richard A. Koup on behalf of the Immune Assays; Moderna, Inc.; Coronavirus Vaccine Prevention Network (CoVPN)/Coronavirus Efficacy (COVE); and United States Government (USG)/CoVPN Biostatistics Teams
doi: https://doi.org/10.1101/2021.08.09.21261290

Article Information

doi 
https://doi.org/10.1101/2021.08.09.21261290
History 
  • August 15, 2021.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Peter B. Gilbert, Ph.D.*,#,1,
  2. David C. Montefiori, Ph.D.*,4,
  3. Adrian McDermott, Ph.D.*,2,
  4. Youyi Fong, Ph.D.1,
  5. David Benkeser, Ph.D.5,
  6. Weiping Deng, Ph.D.8,
  7. Honghong Zhou, Ph.D.8,
  8. Christopher R. Houchens, Ph.D.6,
  9. Karen Martins, Ph.D.6,
  10. Lakshmi Jayashankar, Ph.D.6,
  11. Flora Castellino, M.D.6,
  12. Britta Flach, Ph.D.2,
  13. Bob C. Lin, B.S.2,
  14. Sarah O’Connell, M.S.2,
  15. Charlene McDanal, B.S.4,
  16. Amanda Eaton, M.B.A.4,
  17. Marcella Sarzotti-Kelsoe, Ph.D.4,
  18. Yiwen Lu, M.S.1,
  19. Chenchen Yu, M.S.1,
  20. Bhavesh Borate, M.B.B.S.1,
  21. Lars W. P. van der Laan, M.A.1,
  22. Nima Hejazi, M.S.7,
  23. Chuong Huynh, M.S.6,
  24. Jacqueline Miller, M.D.8,
  25. Hana M. El Sahly, M.D.9,
  26. Lindsey R. Baden, M.D.10,
  27. Mira Baron, M.D.11,
  28. Luis De La Cruz, M.D.12,
  29. Cynthia Gay, M.D.13,
  30. Spyros Kalams, M.D.14,
  31. Colleen F. Kelley, M.D., M.P.H.15,
  32. Mark Kutner, M.D.16,
  33. Michele P. Andrasik, Ph.D.1,
  34. James G. Kublin, M.D.1,
  35. Lawrence Corey, M.D.1,
  36. Kathleen M. Neuzil, M.D.17,
  37. Lindsay N. Carpp, Ph.D.1,
  38. Rolando Pajon, Ph.D.8,
  39. Dean Follmann, Ph.D.3,
  40. Ruben O. Donis, Ph.D.£,6,
  41. Richard A. Koup, M.D.£,2 and
  42. on behalf of the Immune Assays; Moderna, Inc.; Coronavirus Vaccine Prevention Network (CoVPN)/Coronavirus Efficacy (COVE); and United States Government (USG)/CoVPN Biostatistics Teams
  1. 1The Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA
  2. 2The Vaccine Research Center
  3. 3The Biostatistics Research Branch
  4. 4National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD; the Department of Surgery and Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC
  5. 5The Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, GA
  6. 6The Biomedical Advanced Research and Development Authority, Washington, DC
  7. 7Graduate Group in Biostatistics, University ofBerkeley, Berkeley, CA
  8. 8Moderna, Inc., Cambridge, MA
  9. 9Baylor College of Medicine, Houston, TX
  10. 10Brigham and Women’s Hospital, Boston, MA
  11. 11Palm Beach Research Center, West Palm Beach, FL
  12. 12Keystone Vitalink Research, Greenville, SC
  13. 13University of North Carolina, Chapel Hill, NC
  14. 14Vanderbilt University Medical Center, Nashville, TN
  15. 15Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine and the Grady Health System, Atlanta, GA
  16. 16Suncoast Research Group, Miami, FL
  17. 17The Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD
  1. ↵# Corresponding author; email: pgilbert{at}fredhutch.org

  1. ↵* Drs. Peter B. Gilbert, David C. Montefiori, and Adrian McDermott contributed equally to this work.

  2. ↵£ Drs. Ruben O. Donis and Richard A. Koup contributed equally to this work.

Back to top
Posted August 15, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Immune Correlates Analysis of the mRNA-1273 COVID-19 Vaccine Efficacy Trial
Peter B. Gilbert, David C. Montefiori, Adrian McDermott, Youyi Fong, David Benkeser, Weiping Deng, Honghong Zhou, Christopher R. Houchens, Karen Martins, Lakshmi Jayashankar, Flora Castellino, Britta Flach, Bob C. Lin, Sarah O’Connell, Charlene McDanal, Amanda Eaton, Marcella Sarzotti-Kelsoe, Yiwen Lu, Chenchen Yu, Bhavesh Borate, Lars W. P. van der Laan, Nima Hejazi, Chuong Huynh, Jacqueline Miller, Hana M. El Sahly, Lindsey R. Baden, Mira Baron, Luis De La Cruz, Cynthia Gay, Spyros Kalams, Colleen F. Kelley, Mark Kutner, Michele P. Andrasik, James G. Kublin, Lawrence Corey, Kathleen M. Neuzil, Lindsay N. Carpp, Rolando Pajon, Dean Follmann, Ruben O. Donis, Richard A. Koup
medRxiv 2021.08.09.21261290; doi: https://doi.org/10.1101/2021.08.09.21261290
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area